Cryoablation Safer Than RF In Treating Atrial Fib, Trial Sponsor Says
This article was originally published in The Gray Sheet
Executive Summary
CryoCath expects to learn by April whether FDA will require a follow-up period of longer than six months for a pivotal study of the Arctic Front ablation catheter to treat chronic atrial fibrillation
You may also be interested in...
ATS To Promote Mechanical Heart Valves Over Tissue In Younger Patients
ATS Medical will rely on an "indications-based" sales strategy, starting in the second half of 2005 to offset cardiac surgeons' increasing preference for tissue heart valves over mechanical valves
ATS To Promote Mechanical Heart Valves Over Tissue In Younger Patients
ATS Medical will rely on an "indications-based" sales strategy, starting in the second half of 2005 to offset cardiac surgeons' increasing preference for tissue heart valves over mechanical valves
St. Jude Fortifies AF Business With HIFU Market Development, R&D Initiatives
The president of St. Jude Medical's fledgling AF division, Jane Song, is tasked with establishing 10-15 "centers of excellence" in preparation for the firm's high intensity focused ultrasound (HIFU) launch